Opioid Antagonists

Overview

4.6 out of 5 (96 Reviews)

Credits

1.00

Post Assessment Questions

6

Start Date

1 Sep 2023

Last Review Date

1 Sep 2023

Expiration Date

31 Aug 2026

Estimated Time To Finish

60 Minutes


 
Need Help?  If you have a system or content concerns, please contact support@statpearls.com

Activity Description

Opioid receptor antagonists block one or more of the opioid receptors in the central or peripheral nervous system. Opioid receptors are specific transmembrane neurotransmitter receptors that couple G-proteins, which upon stimulation by endogenous or exogenous opioids, lead to the intracellular process of signal transduction. The two most commonly used centrally acting opioid receptor antagonists are naloxone and naltrexone. Naloxone comes in intravenous, intramuscular, and intranasal formulations and is FDA-approved for use in opioid overdose and the reversal of respiratory depression associated with opioid use. Naltrexone is available in both oral and long-acting injectable formulations and is FDA-approved to treat opioid and/or alcohol maintenance treatment. The most commonly used peripheral opioid receptor antagonist is methylnaltrexone, which is a potent competitive antagonist acting in the digestive tract and is also FDA-approved for the treatment of opioid-induced constipation. This activity outlines the indications, mechanism of action, methods of administration, important adverse effects, contraindications, monitoring, and toxicity of opioid antagonists, so providers can direct patient therapy to optimal outcomes to combat opioid overdose, misuse, or adverse effects.


Target Audience

This activity has been designed to meet the educational needs of physicians, physician associates, nurses, pharmacists, and nurse practitioners.

Learning Objectives

At the conclusion of this activity, the learner will be better able to:

  • Identify the mechanism of action of various opioid antagonist medications.

  • Summarize the different indications for the various opioid antagonist agents.

  • Review the adverse event profile of opioid antagonists.

  • Outline the importance of collaboration and communication among interprofessional team members to improve outcomes and treatment efficacy for patients who might benefit from therapy with opioid antagonists, especially in light of the ongoing opioid crisis.

Disclosures

StatPearls, LLC requires everyone who influences the content of an educational activity to disclose relevant financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant conflict(s) of interest have been mitigated. Hover over contributor names for financial disclosures. Others involved in planning this educational activity have no relevant financial relationships to disclose.

Commercial Support: This activity has received NO commercial support.

Continuing Education Accreditation Information

In support of improving patient care, StatPearls, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

Physicians and Physician Associates: StatPearls, LLC designates this enduring material for a maximum of 1.00 AMA PRA Category 1 Credit(s)TM. Physicians and PAs should only claim credit commensurate with the extent of their participation in the activity.

American Board of Anesthesiology: This activity offers up to 1.00 CME credits, of which 1.00 credits contribute to the patient safety CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in AnesthesiologyTM (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0 requirements.

American Board of Internal Medicine: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 MOC points and patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

American Board of Otolaryngology–Head and Neck Surgery: Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn their required annual part II self-assessment credit in the American Board of Otolaryngology–Head and Neck Surgery’s Continuing Certification program (formerly known as MOC). It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of recognizing participation.

American Board of Pathology: Successful completion of this Continuing Certification activity, which includes participation in the evaluation component, enables the participant to earn up to 1.00 Lifelong Learning (CME) credits in the American Board of Pathology’s Continuing Certification Program.

American Board of Pediatrics: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 1.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.

American Board of Surgery: Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn credit toward the CME and Self-Assessment requirement(s) of the American Board of Surgery’s Continuous Certification program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABS credit.

Royal College of Physicians and Surgeons of Canada: Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Please consult your professional licensing board for information on the applicability and acceptance of continuing education credit for this activity.

Method of Participation and Credit

  1. Register for the activity.    
  2. Review the target audience, learning objectives, and disclosure information.
  3. Study the educational content of the enduring material.
  4. Choose the best answer to each activity test question. To receive credit and a certificate, you must pass the test questions with a minimum score of 100%.
  5. Complete the post-activity assessment survey.

If you have concerns regarding the CE/CME system, please contact support@statpearls.com.

Disclaimer

This educational activity was planned and produced in accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education. Faculty may discuss investigational products or off-label uses of products regulated by the FDA. Readers should verify all information before employing any therapies described in this educational activity.

The information provided for this activity is for continuing education purposes only and is not meant to substitute for the independent medical/clinical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The information presented does not necessarily reflect the views of StatPearls or any commercial supporters of educational activities on statpearls.com. StatPearls expressly disclaims responsibility for any adverse consequences resulting directly or indirectly from information in the course, for undetected error, or through a participant's misunderstanding of the content.

Unapproved Uses of Drugs/Devices: In accordance with FDA requirements, the audience is advised that information presented in this continuing education activity may contain references to unlabeled or unapproved uses of drugs or devices. Please refer to the FDA-approved package insert for each drug/device for full prescribing/utilization information.

Cancellation Policy: Please see the cancellation policy. StatPearls, LLC reserves the right to cancel any course due to unforeseen circumstances.

 

 
 

Reviews

JULIE J. on 4/25/2021

Stephanie C. on 6/11/2021

Kchina w. on 8/1/2021

SHEENA M. on 10/9/2021

Debra H. on 10/28/2021

George C. on 11/4/2021

Terri C. on 1/4/2022

Michael M. on 2/14/2022

Lisa D. on 2/25/2022

SANTHA A. on 4/7/2022

Anne C. on 5/15/2022

Melissa D. on 5/29/2022

Lauren I. on 7/6/2022

Marti W. on 7/10/2022

Ashley M. on 7/12/2022

Aimee S. on 7/17/2022

JORGE M. on 7/25/2022

Steve R. on 8/4/2022

Peter M. on 8/17/2022

Gordon C. on 8/27/2022

hary a. on 9/3/2022

Eli N. on 9/20/2022

Jamaica C. on 10/10/2022

Maylin G. on 10/10/2022

Richard S. on 10/23/2022

Rebecca S. on 11/3/2022

Sarah P. on 11/14/2022

margaret c. on 11/20/2022

Ketan H. on 11/25/2022

Lauren K. on 12/5/2022

Effective CE.

Preston S. on 12/11/2022

Spencer R. on 12/18/2022

Leslie B. on 12/23/2022

DONG D. on 12/25/2022

Dr M. on 12/27/2022

Nancy H. on 1/2/2023

Garrett W. on 1/12/2023

kevin n. on 1/20/2023

Andrea H. on 1/23/2023

Lisa T. on 2/1/2023

Jeffrey H. on 2/1/2023

Jennifer A. on 2/3/2023

Melissa L. on 2/7/2023

Shelby H. on 2/10/2023

Kurt C. on 2/12/2023

William I. on 2/13/2023

amy s. on 2/16/2023

Lesly P. on 2/17/2023

Bashiru B. on 2/26/2023

Brandy L. on 3/8/2023

Michelle K. on 3/25/2023

John G. on 3/27/2023

abha s. on 4/4/2023

Daniel H. on 4/10/2023

Deborah M. on 4/11/2023

Kristina C. on 4/19/2023

Philip S. on 5/22/2023

Rosemary W. on 5/30/2023

Joy R. on 6/2/2023

Eugene A. on 6/17/2023

Caroline S. on 6/23/2023

Lea R. on 7/10/2023

Faith C. on 8/26/2023

Michael M. on 9/3/2023

Michael Y. on 9/3/2023

Laura M. on 9/12/2023

Xasan W. on 9/13/2023

Bwayne M. on 9/19/2023

mary m. on 9/20/2023

Joline T. on 9/24/2023

Howard R. on 9/26/2023

James c. on 10/3/2023

Gursimar S. on 10/3/2023

wasim s. on 10/6/2023

Jami P. on 10/18/2023

Meril M. on 11/1/2023

Jane G. on 11/5/2023

Ann C. on 11/10/2023

Christina M. on 12/3/2023

Yaakov W. on 12/22/2023

Purvi P. on 12/22/2023

valerie b. on 12/25/2023

Christopher B. on 12/28/2023

sarah S. on 12/28/2023

ANYA H. on 12/31/2023

sikhumbuzo m. on 1/3/2024

Stephen B. on 1/13/2024

Katherine S. on 1/18/2024

William T. on 1/23/2024

Ivel D. on 1/24/2024

Christopher M. on 1/29/2024

Jarrod G. on 1/29/2024

Dr K. on 1/30/2024

David S. on 2/1/2024

Bhupendra M. on 2/2/2024

Wassim E. on 2/26/2024

Unlimited Physician CME

Stay up to date on the latest medical knowledge with 6682 CME activities. In these online self-assessment activities, read our reference articles and test your knowledge with more than 7934.5 hours of CME.

Learn About Lifetime CME

Single Activity

Take this single activity

$49 1 activity

6 Month Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$399 per half year per user

1 Year Unlimited Physician CME

Access to all the Unlimited Physician CME activities in all specialties.

$599 per 1 year per user